Insulin‐like growth factor I: A mitogen for rat schwann cells in the presence of elevated levels of cyclic AMP
- 1 January 1993
- Vol. 8 (4) , 232-240
- https://doi.org/10.1002/glia.440080403
Abstract
To develop effective procedures for improving the regeneration of peripheral nerves and for preventing the formation of neurofibromas, it is necessary to identify the different mitogens that stimulate the proliferation of Schwann cells. Insulinlike growth factor I (IGF-I), which is a potent autocrine growth factor in many tissues, is synthesized by proliferating Schwann cells. However, the role of IGF-I in stimulating their division is still uncertain. Here we show that nanomolar concentrations of IGF-I stimulate the growth of Schwann cells in primary culture. IGF-I alone was uneffective but in the presence of forskolin (5 μM) or dibutyryl cyclic AMP (dbcAMP, 10 μM), it became a potent mitogen. Neither IGF-II nor epidermal growth factor (EGF) were effective, even in the presence of forskolin. Insulin also stimulated Schwann cell proliferation in the presence of forskolin, but only at micromolar concentration. Receptors for IGF-I were visualized on the Schwann cell surface by indirect immunofluorescence staining using anti-human IGF-I receptor antibodies. Their presence was also assessed by binding assays using [125I]-IGF-I as a ligand. Scatchard analysis showed a single class of high-affinity receptors (Kd = 1.5 nM). Competition studies with unlabeled IGF-I or insulin indicated a half-maximal displacement of [125I]-IGF-I by IGF-I at about 5 nM, while insulin was about 500-fold less effective. The number of binding sites for IGF-I was increased by exposing cells for 3 days to forskolin (- forskolin: about 5,100; + forskolin: about 12,200 binding sites/cell). These results suggest that forskolin increases available receptors for IGF-I, which is consistent with the synergism between cAMP and IGF-I in stimulating Schwann cell growth.Keywords
This publication has 48 references indexed in Scilit:
- Stimulation of rat Schwann cell proliferation by estradiol: synergism between the estrogen and cAMPDevelopmental Brain Research, 1993
- Regulation of Schwann cell proliferation: Mechanisms involved in peripheral nerve developmentExperimental Cell Research, 1992
- Chronic elevation of cAMP levels induces changes in the adenylate cyclase system, opiate receptor sensitivity and levels of Gs-mRNA in cultured neuronsNeuroscience Letters, 1992
- The effects of cAMP on differentiation of cultured Schwann cells: progression from an early phenotype (04+) to a myelin phenotype (P0+, GFAP-, N-CAM-, NGF-receptor-) depends on growth inhibition.The Journal of cell biology, 1991
- Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathwayNature, 1990
- Cloning and characterization of the proximal promoter region of the rat insulin-like growth factor I (IGF-I) receptor geneBiochemical and Biophysical Research Communications, 1990
- Macrophages and microglia in the nervous systemTrends in Neurosciences, 1988
- Control of peripheral glial cell proliferation: A comparison of the division rates of enteric glia and Schwann cells and their response to mitogensDevelopmental Biology, 1987
- Evidence indicating trophic importance of IGF‐1 in regenerating peripheral nervesActa Physiologica Scandinavica, 1986
- The role of non-resident cells in Wallerian degenerationJournal of Neurocytology, 1984